The ECOG-ACRIN SUPPORT Trial: Improving Diverse Enrollment in Cancer Clinical Trials
This study, called the ECOG-ACRIN SUPPORT Trial, is looking at ways to help more Black and Latino cancer patients learn about and join cancer clinical trials. It tests a program called the SUPPORT toolkit, which includes a website and help from a SUPPORT navigator (a person who guides you through the process). The goal is to see if this toolkit can increase the number of Black and Latino patients referred to and enrolled in NCI-supported clinical trials. You may be able to join if you are an oncology patient at a participating NCORP site, are 18 or older, and identify as Black and/or Latino. The study will measure how many participants are referred to trials over 12 months.
- Study design
- This study is a cluster-randomized trial involving 500 Black and Latino cancer patients. It is designed to evaluate the effectiveness of the SUPPORT intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participant referral will be measured at the end of 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
At a glance
Conditions
Where it's being run
67 sites across 10 statesStudy leadership
- Melissa A Simon, MD, MPH · STUDY_CHAIR · Eastern Cooperative Oncology Group
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Participant ReferralEnd of 12 months
Participant referral to any NCI-supported CT assessed at the end of the 12 months of intervention stage, which will be collected from the referral tracking sheet during the intervention